Cardiac monitoring in TIA patients yielded a pooled atrial fibrillation detection rate of 6.5%, with implantable monitors detecting more AF than non-invasive methods (20.8% vs 4.7%, p<0.0001).
Meta-Analysis (n=3,981)
Does prolonged or implantable cardiac monitoring increase the detection rate of atrial fibrillation in patients with transient ischaemic attack?
Prolonged cardiac monitoring, particularly with implantable devices, yields high rates of newly detected atrial fibrillation in patients following a transient ischaemic attack.
BACKGROUND AND AIMS: The optimal monitoring strategy for atrial fibrillation (AF) detection after transient ischaemic attacks (TIA) is uncertain, as existing evidence is largely derived from ischaemic stroke or mixed stroke-TIA populations. This systematic review and meta-analysis aimed to determine the rate of newly diagnosed AF in TIA patients using different electrocardiographic monitoring modalities and durations. METHODS: A literature search from 1966 through May 31, 2025, was conducted according to PRISMA guidelines using a protocol registered on PROSPERO (CRD420251075716). Prospective observational studies and randomised controlled trials including TIA patients who underwent at least 12 hours of cardiac monitoring were eligible. The primary outcome was newly detected AF lasting at least 30 seconds, with subgroup analyses by monitoring duration and modality. RESULTS: Forty-two studies enrolling 3,981 TIA patients were included. The pooled AF detection rate was 6.5% (95% CI: 4.5-9.3%). AF detection rates increased with monitoring duration: 3.5% at 1 day, 6.3% at 7 days, 9.6% at 30 days, 13.1% at 90 days, and 19.1% at 12 months, respectively. Implantable cardiac monitors yielded statistically significantly higher AF detection rates than non-invasive cardiac monitoring (20.8% vs. 4.7%, p < 0.0001). AF detection appeared higher in selected cohorts (based on older age, undetermined cause, and more extensive cardiovascular work-up) than unselected cohorts (9.0% vs 4.5, p=0.031). However, stratified analysis of non-invasive monitoring showed no difference between selected and unselected TIA patients (5.0% 95% CI: 2.3-10.5% vs 4.5% 95% CI: 3.1-6.5%). Substantial heterogeneity was observed among studies (I² = 81.9 %). CONCLUSION: This meta-analysis found high rates of newly detected AF in TIA patients undergoing prolonged cardiac monitoring, which are similar to rates previously reported after ischaemic stroke. Studies using implantable cardiac monitors specifically in TIA patients are scarce. Randomised trials are needed for a face-to-face comparison of different monitoring strategies and to determine whether prolonged cardiac monitoring improves clinical outcome in TIA patients.
Veltkamp et al. (Wed,) conducted a meta-analysis in Transient ischaemic attacks (TIA) (n=3,981). Cardiac monitoring was evaluated on Newly detected AF lasting at least 30 seconds (95% CI 4.5-9.3). Cardiac monitoring in TIA patients yielded a pooled atrial fibrillation detection rate of 6.5%, with implantable monitors detecting more AF than non-invasive methods (20.8% vs 4.7%, p<0.0001).